{"schema_version":"secwatch.filing_event.v1","accession":"0002070849-26-000010","form_type":"8-K","ticker":"BLLN","cik":"0002070849","company_name":"BillionToOne, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.161877+00:00","generated_at":"2026-05-16T10:58:43.227665+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BillionToOne guides FY2026 revenue $415-430M, up ~43% YoY; positive operating income","bullets":["Reiterated FY2025 revenue guidance of $293M-$299M with positive GAAP operating income.","Initiated FY2026 revenue guidance of $415M-$430M, representing 40-45% growth over FY2025 midpoint.","Expects positive GAAP operating income for full year 2026.","CEO highlights scaling of differentiated molecular diagnostics platform and durable growth."],"urls":{"canonical":"https://secwatch.observer/filing/0002070849-26-000010","json":"https://secwatch.observer/filing/0002070849-26-000010.json","markdown":"https://secwatch.observer/filing/0002070849-26-000010.md","text":"https://secwatch.observer/filing/0002070849-26-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2070849/000207084926000010/0002070849-26-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2070849/000207084926000010/blln-20260112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:58:43.227665+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}